Metastasis: a question of life or death (original) (raw)

• Weigelt, B., Peterse, J. L. & van 't Veer, L. J. Breast cancer metastasis: markers and models. Nature Rev. Cancer 5, 591–602 (2005).
  CAS Google Scholar
• Salvesen, G. S. & Dixit, V. M. Caspases: intracellular signaling by proteolysis. Cell 91, 443–446 (1997).
  CAS PubMed Google Scholar
• Zimmermann, K. C. & Green, D. R. How cells die: apoptosis pathways. J. Allergy Clin. Immunol. 108, S99–S103 (2001).
  CAS PubMed Google Scholar
• Salvesen, G. S. & Duckett, C. S. IAP proteins: blocking the road to death's door. Nature Rev. Mol. Cell Biol. 3, 401–410 (2002).
  CAS Google Scholar
• Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000). A seminal review describing the main rules that govern the transformation of normal human cells into malignant cancers.
  CAS PubMed Google Scholar
• Yin, C., Knudson, C. M., Korsmeyer, S. J. & Van Dyke, T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385, 637–640 (1997).
  CAS PubMed Google Scholar
• Lowe, S. W., Cepero, E. & Evan, G. Intrinsic tumour suppression. Nature 432, 307–315 (2004).
  CAS PubMed Google Scholar
• Fidler, I. J. & Nicolson, G. L. Fate of recirculating B16 melanoma metastatic variant cells in parabiotic syngeneic recipients. J. Natl Cancer Inst. 58, 1867–1872 (1977).
  CAS PubMed Google Scholar
• Liotta, L. A., Vembu, D., Saini, R. K. & Boone, C. In vivo monitoring of the death rate of artificial murine pulmonary micrometastases. Cancer Res. 38, 1231–1236 (1978).
  CAS PubMed Google Scholar
• Varani, J., Lovett, E. J., Elgebaly, S., Lundy, J. & Ward, P. A. In vitro and in vivo adherence of tumor cell variants correlated with tumor formation. Am. J. Pathol. 101, 345–352 (1980).
  CAS PubMed PubMed Central Google Scholar
• Inbal, B. et al. DAP kinase links the control of apoptosis to metastasis. Nature 390, 180–184 (1997). By using lung carcinoma clones, this study shows that the inhibition of the expression of DAPK, a positive mediator of apoptosis, favours the metastatic process.
  CAS PubMed Google Scholar
• Um, J. H. et al. Relationship between antiapoptotic molecules and metastatic potency and the involvement of DNA-dependent protein kinase in the chemosensitization of metastatic human cancer cells by epidermal growth factor receptor blockade. J. Pharmacol. Exp. Ther. 311, 1062–1070 (2004).
  CAS PubMed Google Scholar
• Glinsky, G. V., Glinsky, V. V., Ivanova, A. B. & Hueser, C. J. Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms. Cancer Lett. 115, 185–193 (1997). Data showing that the metastatic potential of murine and human cancer cells is strictly associated with the increased resistance to apoptosis.
  CAS PubMed Google Scholar
• Del Bufalo, D., Biroccio, A., Leonetti, C. & Zupi, G. Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line. FASEB J. 11, 947–953 (1997). An elegant study showing that the overexpression of the anti-apoptotic oncoprotein BCL2 increases the metastatic potential of human breast cancer cells.
  CAS PubMed Google Scholar
• McConkey, D. J., Greene, G. & Pettaway, C. A. Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line. Cancer Res. 56, 5594–5599 (1996).
  CAS PubMed Google Scholar
• Furuya, Y., Krajewski, S., Epstein, J. I., Reed, J. C. & Isaacs, J. T. Expression of bcl-2 and the progression of human and rodent prostatic cancers. Clin. Cancer Res. 2, 389–398 (1996).
  CAS PubMed Google Scholar
• Owen-Schaub, L. B., van Golen, K. L., Hill, L. L. & Price, J. E. Fas and Fas ligand interactions suppress melanoma lung metastasis. J. Exp. Med. 188, 1717–1723 (1998).
  CAS PubMed PubMed Central Google Scholar
• Thompson, T. C. et al. Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer. Oncogene 10, 869–879 (1995).
  CAS PubMed Google Scholar
• Silvestrini, R. et al. Validation of p53 accumulation as a predictor of distant metastasis at 10 years of follow-up in 1400 node-negative breast cancers. Clin. Cancer Res. 2, 2007–2013 (1996).
  CAS PubMed Google Scholar
• Lewis, B. C. et al. The absence of p53 promotes metastasis in a novel somatic mouse model for hepatocellular carcinoma. Mol. Cell. Biol. 25, 1228–1237 (2005).
  CAS PubMed PubMed Central Google Scholar
• Ko, J. et al. Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice. Oncogene 23, 1950–1953 (2004).
  CAS PubMed Google Scholar
• Esteller, M. Relevance of DNA methylation in the management of cancer. Lancet Oncol. 4, 351–358 (2003).
  CAS PubMed Google Scholar
• Bao, S. et al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 5, 329–339 (2004).
  CAS PubMed Google Scholar
• Martin, S. S. & Vuori, K. Regulation of Bcl-2 proteins during anoikis and amorphosis. Biochim. Biophys. Acta 1692, 145–157 (2004). A detailed analysis of the molecular mechanisms of apoptosis induced during anoikis and amorphosis.
  CAS PubMed Google Scholar
• Streuli, C. H. & Gilmore, A. P. Adhesion-mediated signaling in the regulation of mammary epithelial cell survival. J. Mammary Gland. Biol. Neoplasia 4, 183–191 (1999).
  CAS PubMed Google Scholar
• Martin, S. S. & Leder, P. Human MCF10A mammary epithelial cells undergo apoptosis following actin depolymerization that is independent of attachment and rescued by Bcl-2. Mol. Cell. Biol. 21, 6529–6536 (2001).
  CAS PubMed PubMed Central Google Scholar
• Puthalakath, H., Huang, D. C., O'Reilly, L. A., King, S. M. & Strasser, A. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell 3, 287–296 (1999).
  CAS PubMed Google Scholar
• Puthalakath, H. et al. Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science 293, 1829–1832 (2001).
  CAS PubMed Google Scholar
• Zhu, Z. et al. Anoikis and metastatic potential of cloudman S91 melanoma cells. Cancer Res. 61, 1707–1716 (2001).
  CAS PubMed Google Scholar
• Owens, L. V. et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res. 55, 2752–2755 (1995).
  CAS PubMed Google Scholar
• McLean, G. W. et al. Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. Genes Dev. 18, 2998–3003 (2004).
  CAS PubMed PubMed Central Google Scholar
• Gentile, A. & Comoglio, P. M. Invasive growth: a genetic program. Int. J. Dev. Biol. 48, 451–456 (2004).
  CAS PubMed Google Scholar
• Camp, E. R. et al. RON, a tyrosine kinase receptor involved in tumor progression and metastasis. Ann. Surg. Oncol. 12, 273–281 (2005).
  PubMed Google Scholar
• Peace, B. E., Toney-Earley, K., Collins, M. H. & Waltz, S. E. Ron receptor signaling augments mammary tumor formation and metastasis in a murine model of breast cancer. Cancer Res. 65, 1285–1293 (2005).
  CAS PubMed Google Scholar
• Zeng, Q. et al. Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFκB. J. Biol. Chem. 277, 25203–25208 (2002).
  CAS PubMed Google Scholar
• Pinkas, J., Martin, S. S. & Leder, P. Bcl-2-mediated cell survival promotes metastasis of EpH4 βMEKDD mammary epithelial cells. Mol. Cancer Res. 2, 551–556 (2004).
  CAS PubMed Google Scholar
• Martin, S. S. et al. A cytoskeleton-based functional genetic screen identifies Bcl-xL as an enhancer of metastasis, but not primary tumor growth. Oncogene 23, 4641–4645 (2004). An elegant study identifying BCL-X L as a suppressor of cytoskeleton-dependent death and that overexpression in mouse mammary epithelial cells does not induce primary tumour formation but strongly increases metastatic potential.
  CAS PubMed Google Scholar
• Olopade, O. I. et al. Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J. Sci. Am. 3, 230–237 (1997).
  CAS PubMed Google Scholar
• Fernandez, Y., Gu, B., Martinez, A., Torregrosa, A. & Sierra, A. Inhibition of apoptosis in human breast cancer cells: role in tumor progression to the metastatic state. Int. J. Cancer 101, 317–326 (2002).
  CAS PubMed Google Scholar
• Berezovskaya, O. et al. Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells. Cancer Res. 65, 2378–2386 (2005). Comprehensive work showing that the apoptosis-inhibitory protein XIAP contributes to the anoikis resistance of circulating metastatic prostate cancer cells.
  CAS PubMed Google Scholar
• Shen, T. L. et al. Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis. J. Cell Biol. 169, 941–952 (2005).
  CAS PubMed PubMed Central Google Scholar
• Wyckoff, J. B., Jones, J. G., Condeelis, J. S. & Segall, J. E. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res. 60, 2504–2511 (2000).
  CAS PubMed Google Scholar
• Fidler, I. J. Metastasis: guantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2′-deoxyuridine. J. Natl Cancer Inst. 45, 773–782 (1970).
  CAS PubMed Google Scholar
• Wong, C. W. et al. Apoptosis: an early event in metastatic inefficiency. Cancer Res. 61, 333–338 (2001).
  CAS PubMed Google Scholar
• Luzzi, K. J. et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol. 153, 865–873 (1998). References 43, 44 and 45 examine the fate of cancer cells in the blood stream and in the site of metastasis, aiming to identify mechanisms explaining the overall metastatic inefficiency.
  CAS PubMed PubMed Central Google Scholar
• Jakobisiak, M., Lasek, W. & Golab, J. Natural mechanisms protecting against cancer. Immunol. Lett. 90, 103–122 (2003).
  CAS PubMed Google Scholar
• Pardoll, D. Does the immune system see tumors as foreign or self? Annu. Rev. Immunol. 21, 807–839 (2003).
  CAS PubMed Google Scholar
• Dunn, G. P., Old, L. J. & Schreiber, R. D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137–148 (2004).
  CAS PubMed Google Scholar
• Rosenberg, S. A. et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N. Engl. J. Med. 313, 1485–1492 (1985).
  CAS PubMed Google Scholar
• Rosenberg, S. A. Progress in human tumour immunology and immunotherapy. Nature 411, 380–384 (2001).
  CAS PubMed Google Scholar
• Kim, S., Iizuka, K., Aguila, H. L., Weissman, I. L. & Yokoyama, W. M. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc. Natl Acad. Sci. USA 97, 2731–2736 (2000).
  CAS PubMed PubMed Central Google Scholar
• Smyth, M. J. et al. NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer. J. Exp. Med. 200, 1325–1335 (2004).
  CAS PubMed PubMed Central Google Scholar
• Takeda, K. et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-γ-dependent suppression of subcutaneous tumor growth. Cell Immunol. 214, 194–200 (2001).
  CAS PubMed Google Scholar
• Cretney, E. et al. Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J. Immunol. 168, 1356–1361 (2002).
  CAS PubMed Google Scholar
• Weiss, L., Elkin, G. & Barbera-Guillem, E. The differential resistance of B16 wild-type and F10 cells to mechanical trauma in vitro. Invasion Metastasis 13, 92–101 (1993).
  CAS PubMed Google Scholar
• Ziegler, T., Silacci, P., Harrison, V. J. & Hayoz, D. Nitric oxide synthase expression in endothelial cells exposed to mechanical forces. Hypertension 32, 351–355 (1998).
  CAS PubMed Google Scholar
• Wang, H. H. et al. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis. Cancer Res. 60, 5862–5869 (2000).
  CAS PubMed Google Scholar
• Edmiston, K. H. et al. Role of nitric oxide and superoxide anion in elimination of low metastatic human colorectal carcinomas by unstimulated hepatic sinusoidal endothelial cells. Cancer Res. 58, 1524–1531 (1998).
  CAS PubMed Google Scholar
• Jaattela, M., Wissing, D., Kokholm, K., Kallunki, T. & Egeblad, M. Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J. 17, 6124–6134 (1998).
  CAS PubMed PubMed Central Google Scholar
• Kluger, H. M. et al. Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease. Cancer Res. 65, 5578–5587 (2005).
  CAS PubMed Google Scholar
• Schmitt, C. A. et al. Dissecting p53 tumor suppressor functions in vivo. Cancer Cell 1, 289–298 (2002).
  CAS PubMed Google Scholar
• Nikiforov, M. A. et al. p53 modulation of anchorage independent growth and experimental metastasis. Oncogene 13, 1709–1719 (1996). Data showing that the inactivation of p53 in transformed mouse embryonic fibroblasts facilitates experimental metastasis by promoting the survival of tumour cells in circulation.
  CAS PubMed Google Scholar
• Schuler, M. & Green, D. R. Transcription, apoptosis and p53: catch-22. Trends Genet. 21, 182–187 (2005).
  CAS PubMed Google Scholar
• Ponta, H., Sherman, L. & Herrlich, P. A. CD44: from adhesion molecules to signalling regulators. Nature Rev. Mol. Cell Biol. 4, 33–45 (2003).
  CAS Google Scholar
• Yu, Q., Toole, B. P. & Stamenkovic, I. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J. Exp. Med. 186, 1985–1996 (1997).
  CAS PubMed PubMed Central Google Scholar
• O'Reilly, M. S. et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315–328 (1994).
  CAS PubMed Google Scholar
• O'Reilly, M. S., Holmgren, L., Chen, C. & Folkman, J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med. 2, 689–692 (1996).
  CAS PubMed Google Scholar
• O'Reilly, M. S. et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277–285 (1997).
  CAS PubMed Google Scholar
• Giehl, K. Oncogenic Ras in tumour progression and metastasis. Biol. Chem. 386, 193–205 (2005).
  CAS PubMed Google Scholar
• Liao, Y. et al. Modulation of apoptosis, tumorigenesity and metastatic potential with antisense H-ras oligodeoxynucleotides in a high metastatic tumor model of hepatoma: LCI-D20. Hepatogastroenterology 47, 365–370 (2000).
  CAS PubMed Google Scholar
• Varghese, H. J. et al. Activated ras regulates the proliferation/apoptosis balance and early survival of developing micrometastases. Cancer Res. 62, 887–891 (2002). By using in vivo video microscopy and detailed cell quantification, this study provides evidence for a direct role for Ras in the maintenance of metastatic growth by mediating a shift in the proliferation/apoptosis balance.
  CAS PubMed Google Scholar
• Mehlen, P. The dependence receptor notion: another way to see death. Cell Death Differ. 12, 1003 (2005).
  CAS PubMed Google Scholar
• Mehlen, P. & Bredesen, D. E. The dependence receptor hypothesis. Apoptosis 9, 37–49 (2004).
  CAS PubMed Google Scholar
• Mehlen, P. & Thibert, C. Dependence receptors: between life and death. Cell Mol. Life Sci. 61, 1854–1866 (2004).
  CAS PubMed Google Scholar
• Bredesen, D. E., Mehlen, P. & Rabizadeh, S. Receptors that mediate cellular dependence. Cell Death Differ. 12, 1031–1043 (2005).
  CAS PubMed Google Scholar
• Wang, J. J. et al. Dimerization-dependent block of the proapoptotic effect of p75(NTR). J. Neurosci. Res. 60, 587–593 (2000).
  CAS PubMed Google Scholar
• Forcet, C. et al. The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation. Proc. Natl Acad. Sci. USA 98, 3416–3421 (2001).
  CAS PubMed PubMed Central Google Scholar
• Stupack, D. G., Puente, X. S., Boutsaboualoy, S., Storgard, C. M. & Cheresh, D. A. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol. 155, 459–470 (2001).
  CAS PubMed PubMed Central Google Scholar
• Mehlen, P. & Furne, C. Netrin-1: when a neuronal guidance cue turns out to be a regulator of tumorigenesis. Cell Mol. Life Sci. 62, 2599–2616 (2005).
  CAS PubMed Google Scholar
• Fearon, E. R. et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247, 49–56 (1990).
  CAS PubMed Google Scholar
• Mehlen, P. & Fearon, E. R. Role of the dependence receptor DCC in colorectal cancer pathogenesis. J. Clin. Oncol. 22, 3420–3428 (2004).
  CAS PubMed Google Scholar
• Thiebault, K. et al. The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment. Proc. Natl Acad. Sci. USA 100, 4173–4178 (2003).
  CAS PubMed PubMed Central Google Scholar
• Mehlen, P. et al. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 395, 801–804 (1998).
  CAS PubMed Google Scholar
• Llambi, F., Causeret, F., Bloch-Gallego, E. & Mehlen, P. Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. EMBO J. 20, 2715–2722 (2001).
  CAS PubMed PubMed Central Google Scholar
• Mazelin, L. et al. Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature 431, 80–84 (2004). This paper suggests for the first time, using a mouse model, that dependence receptors might regulate tumorigenesis.
  CAS PubMed Google Scholar
• Llambi, F. et al. The dependence receptor UNC5H2 mediates apoptosis through DAP-kinase. EMBO J. 24, 1192–1201 (2005).
  CAS PubMed PubMed Central Google Scholar
• Tanikawa, C., Matsuda, K., Fukuda, S., Nakamura, Y. & Arakawa, H. p53RDL1 regulates p53-dependent apoptosis. Nature Cell Biol. 5, 216–223 (2003).
  CAS PubMed Google Scholar
• Stupack, D. G. Integrins as a distinct subtype of dependence receptors. Cell Death Differ. 12, 1021–1030 (2005).
  CAS PubMed Google Scholar
• Stupack, D. G. et al. Potentiation of neuroblastoma metastasis by loss of caspase 8. Nature 439 95–99 (2006). This paper represents the first demonstration of a role for dependence receptors in metastasis regulation.
  CAS PubMed Google Scholar
• Hofmann, U. B., Houben, R., Brocker, E. B. & Becker, J. C. Role of matrix metalloproteinases in melanoma cell invasion. Biochimie 87, 307–314 (2005).
  CAS PubMed Google Scholar
• Abraham, R. et al. Identification of MMP-15 as an anti-apoptotic factor in cancer cells. J. Biol. Chem. 280, 34123–34132 (2005).
  CAS PubMed Google Scholar
• Strand, S. et al. Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells. Oncogene 23, 3732–3736 (2004).
  CAS PubMed Google Scholar
• Huber, M. A. et al. NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J. Clin. Invest. 114, 569–581 (2004).
  CAS PubMed PubMed Central Google Scholar
• Chen, Z. F. & Behringer, R. R. Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev. 9, 686–699 (1995).
  CAS PubMed Google Scholar
• Yang, J. et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927–939 (2004).
  CAS PubMed Google Scholar
• Maestro, R. et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev. 13, 2207–2217 (1999).
  CAS PubMed PubMed Central Google Scholar
• Valsesia-Wittmann, S. et al. Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Cancer Cell 6, 625–630 (2004). References 95, 96 and 97 show the oncogenic properties of H-Twist, highlighting its role as an anti-apoptotic factor (references 96 and 97), and establishing its implication in the metastatic process (reference 95).
  CAS PubMed Google Scholar
• Puisieux, A., Valsesia-Wittmann, S. & Ansieau, S. A twist for survival and cancer progression. Br. J. Cancer 94, 13–17 (2006).
  CAS PubMed Google Scholar
• Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R. & Leder, P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54, 105–115 (1988).
  CAS PubMed Google Scholar
• Greenberg, N. M., et al. Prostate cancer in a transgenic mouse. Proc. Natl Acad. Sci. USA 92, 3439–3443 (1995)
  CAS PubMed PubMed Central Google Scholar
• Sierra, A. Metastases and their microenvironments: linking pathogenesis and therapy. Drug Resist. Updat. 8, 247–257 (2005).
  CAS PubMed Google Scholar
• Fesik, S. W. Promoting apoptosis as a strategy for cancer drug discovery. Nature Rev. Cancer 5, 876–885 (2005).
  CAS Google Scholar